Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.
Press releases published on August 12, 2025

Minimally Invasive Glaucoma Surgery (MIGS) Device Market is Expected to Hit USD 5.11 Billion by 2034
As healthcare systems globally increasingly prioritize patient-centric approaches, the demand for sophisticated MIGS devices is expected to grow exponentially. US, NY, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- The global Minimally Invasive …

CityDrinks Launches Genie, the AI Sommelier Revolutionizing Beverage Selection in the UAE
UAE’s leading online alcohol delivery service unveils Genie—AI-powered recommendations tailored to your taste, mood, and occasion. ABU DHABI, UNITED ARAB EMIRATES, August 12, 2025 /EINPresswire.com/ -- CityDrinks, the UAE’s leading online alcohol …

Alarum to Release Second Quarter 2025 Results on August 28, 2025
Conference call scheduled for Thursday, August 28, 2025, at 8:30 a.m. ET Tel Aviv, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq, TASE: ALAR), a global provider of web data collection solutions, will release its financial …

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy
CHICAGO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, announced today that it has commenced purchases of Ethereum (ETH), advancing its …

Falcon Technic Returns Global Express XRS Back to the Skies After Major Maintenance
DUBAI, United Arab Emirates, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Falcon Technic, part of Alex Group Investment, has successfully completed a major 60-month inspection on the Global Express XRS (A6-AFC), highlighting the base maintenance capabilities of its …

Rio Silver Amends Maria Norte Terms
VANCOUVER, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that, further to the announcements on March 26 and June 25, 2025 (collectively, the “Prior Announcements”), …

Quoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton
ASHBURN, Va., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced the release of the fourth …

Critical Metal Corps Strengthens Management Team With Appointment of Mathias Barfod as President of Greenland Operations
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced the appointment of Mathias Barfod as the Company’s President of …

Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates
Secured over $111 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by over $71 million in committed capital from Medtronic and Ligand Achieved multiple FDA …

Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GRAND CAYMAN, Cayman Islands, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company developing RNA interference (RNAi) therapies for KRAS-driven cancers, today …

PolyPid Appoints Dr. Nurit Tweezer-Zaks as Chief Medical Officer
PETACH TIKVA, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Dr. Nurit Tweezer-Zaks, M.D., M.B.A., …

Aprea Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Clinical Update
Early evidence of disease control was observed in the ongoing Phase 1 ACESOT-1051 trial, with three patients achieving stable disease in the 70 mg and 100 mg cohorts treated with the WEE1 inhibitor, APR-1051 $16.5 million in cash and cash equivalents as of …

Cerevance to Participate in Piper Sandler Virtual CNS Symposium
BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment of neurodegenerative diseases and obesity, today announced participation at the Piper Sandler …

Aardvark Therapeutics Announces ARD-201 Preclinical Obesity Data Showing Significant Weight Loss as a Monotherapy, Enhancement of GLP-1RA Therapy in Combination, and Effective Maintenance Following Discontinuation of GLP-1RA Therapy
In a gold-standard model of obesity, treatment with ARD-201 resulted in approximately 19% body weight reduction after 30 days of treatment. ARD-201 was also associated with attenuated weight regain after discontinuation of tirzepatide. In combination with …

Century Announces Filing of First Quarter Financial Results and Management Discussion and Analysis for the Three Months Ended June 30, 2025
HONG KONG, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Century Global Commodities Corporation (“Century” or the “Company”) (TSX: CNT) is pleased to announce that it has filed its condensed consolidated interim financial statements for the first fiscal quarter ended …

Nanox Announces Second Quarter of 2025 Financial Results and Provides Business Update
Management to host conference call and webcast Tuesday, August 12, 2025 at 8:30 AM ET Company continued to grow Nanox.ARC installed base and is on track to meet its year-end system deployment target PETAH TIKVA, Israel, Aug. 12, 2025 (GLOBE NEWSWIRE) -- …

Integral Metals Provides Update on 2025 Drilling at the KAP Project
CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to provide an update on its 2025 diamond drilling program at the KAP Project in the Northwest Territories …

Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights
Data from Phase 3 Orbit and Cosmic studies of setrusumab in osteogenesis imperfecta expected around year-end 2025 Cash of $56.1 million as of June 30, 2025, expected to support operations into 2027 LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Mereo BioPharma …

Westkam Gold Corp. Provides Update on Management Cease Trade Order
Vancouver, BC, Canada, Aug. 12, 2025 (GLOBE NEWSWIRE) -- WestKam Gold Corp. (TSXV:WKG) (the “Company” or “WestKam”), is providing a bi-weekly default status report in accordance with National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"). On …

Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
FDA Accepted the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray; New PDUFA Target Date of December 13, 2025 Milestone Strengthens Balance Sheet to Fully Commercialize CARDAMYST if Approved Public Offering Raised Total Gross Proceeds …